Ruohui Huang, Bo Jiang, Gang Xu, Haidong Zhong, Jiexia Xiong. Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model. // International Immunopharmacology. – DOI: 10.1016/j.intimp.2026.117611. – URL: https://www.sciencedirect.com/science/article/pii/S1567576926014591?dgcid=rss_sd_all
Ruohui Huang, Bo Jiang, Gang Xu, Haidong Zhong, & Jiexia Xiong Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117611
Ruohui Huang, et al. “Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model.” International Immunopharmacology. doi:10.1016/j.intimp.2026.117611.
@article{Huang,
title = {Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model},
author = {Huang, Ruohui and Jiang, Bo and Xu, Gang and Zhong, Haidong and Xiong, Jiexia},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117611},
url = {https://www.sciencedirect.com/science/article/pii/S1567576926014591?dgcid=rss_sd_all}
}